Recently, chemical genetics using targeted TIPARP mutation and NAD+ analogs have been used to characterize the TIPARP (PARP7) ADP-ribosylated proteome in HEK293, ovarian (OVCAR4) cancer cells and HeLa cells (Palavalli Parsons et al., 2021; Rodriguez et al., 2021). This evidence concerns the gene TIPARP and cancer.